Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px
Document › Details

Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Billerica, MA.

Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
  Organisation 2 J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 42nd Annual Healthcare Conference 2024 San Francisco
  Product 2 analytical instrument
Index term Index term Bruker–JPMorgan Chase: investor conference, 202401 supply service Bruker presents at JP Morgan Healthcare Conference 2024
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Munch, Mark R. (Bruker Corp 201407 President Bruker MAT Group before President Bruker Nano Surfaces Business)
     


Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 42nd annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 8th, 2024 at 8:15 AM Pacific Standard Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.


About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.


Justin Ward
Sr. Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com

   
Record changed: 2025-01-20

Advertisement

Picture Stier Group MIXiii 2025 Lifescience Healthtech Conference 650x200px

More documents for Bruker (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Swiss Biotech Association MSC Global Village 2025 Basel 650x300px




» top